A carregar...

Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells

BACKGROUND AND AIMS: The activating mutation BRAF(V600E) is a frequent genetic event in papillary thyroid carcinomas (PTC). Mutation BRAF(V600E) is associated with the loss of a sodium/iodine symporter (NIS), and subsequent radioiodide-refractory (RAI) metastatic disease. Use of BRAF V600E inhibitor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thyroid Res
Main Authors: Zhang, Honglai, Chen, Dong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6180498/
https://ncbi.nlm.nih.gov/pubmed/30337961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13044-018-0057-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!